Related Experiment Videos
Reactive metabolites and agranulocytosis
1Faculty of Pharmacy, University of Toronto, Canada.
European Journal of Haematology. Supplementum
|January 1, 1996
Summary
Reactive metabolites from certain drugs, formed by neutrophils and hypochlorous acid, are linked to blood disorders like agranulocytosis and aplastic anemia. These metabolites can trigger immune responses or cell damage, affecting neutrophil precursors and stem cells.
Area of Science:
- Hematology
- Toxicology
- Immunology
Background:
- Idiosyncratic drug-induced blood dyscrasias are often hypothesized to involve reactive metabolites.
- These reactive metabolites are likely formed near affected blood cells.
Purpose of the Study:
- To investigate the role of neutrophil oxidative systems in forming reactive metabolites from drugs.
- To elucidate the mechanisms by which these metabolites induce agranulocytosis and aplastic anemia.
Main Methods:
- Demonstration of drug oxidation to reactive metabolites by hypochlorous acid and/or activated neutrophils.
- Analysis of mechanisms including drug-dependent anti-neutrophil antibodies and cell-mediated immune reactions.
Main Results:
- Drugs causing high agranulocytosis incidence are oxidized to reactive metabolites by hypochlorous acid/activated neutrophils.
- Reactive metabolites can induce agranulocytosis via anti-neutrophil antibodies or cytotoxicity to neutrophil precursors.
- Reactive metabolites may also contribute to aplastic anemia through cytotoxic T cells.
Conclusions:
- Neutrophil-generated reactive metabolites play a key role in drug-induced agranulocytosis.
- Mechanisms involve immune responses and direct cellular toxicity to hematopoietic cells.
- Further research into these pathways could inform drug safety and therapeutic strategies.